Lucid Diagnostics Inc.
LUCD
NASDAQ·Healthcare·Medical - Devices·Mkt cap $179.2M
$0.94
▼ -1.23%
P/E
-1.15
Mkt Cap
$179.2M
52-Wk Range
$0.86–$1.63
52-Week Range
$0.86 - $1.63
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 23.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary esophageal DNA testing technology with clinical validation
- Non-invasive cell collection device improving patient compliance
- First-mover advantage in esophageal adenocarcinoma early detection
- Subsidiary support from PAVmed Inc. providing operational resources
Bear Case
1 risk
- Average volatility.
Growth
Strong growth ahead
Rising GERD prevalence and increased cancer screening awareness
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Stable
-1.9% over 3m
Quality
Loss-making
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying LUCD right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 11, 2026
AUG 13, 2026
Reported EPS of -$0.06 vs -$0.06 consensus (-5.9% surprise). Revenue of $1.5M vs $1.4M expected (+3.3%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-5.9%
Revenue trend · last 8Q
—
—
—
+15%
-17%
+19%
+3%
+26%
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
$1.0M
$976.0K
$1.2M
$1.2M
$828.0K
$1.2M
$1.2M
$1.5M
Margins · last 8Q
Gross
-37.6%
Profit
-1081.5%
Wall Street consensus
4 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Ascendiant Capital · Aug 27, 2026
vs Industry
How LUCD stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related